Compare Helmerich & Payne Inc. Common Stock (HP) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Helmerich & Payne Inc. Common Stock vs Kymera Therapeutics Inc. Common Stock — how do they compare? Helmerich & Payne Inc. Common Stock trades at $38.25 (market cap $3.91B), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 2.3× Helmerich & Payne Inc. Common Stock's market cap, and Helmerich & Payne Inc. Common Stock pays a 2.56% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Helmerich & Payne Inc. Common Stock for 0 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| HP | KYMR | |
|---|---|---|
Market Cap | $3.91B | $8.87B |
Volume | 800,382 | 779,107 |
Sector | Energy | Health |
52-Week High | $47.64 | $127.31 |
52-Week Low | $23.11 | $55.80 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.54B | $8.26B |
Dividend Yield | 2.56% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Helmerich & Payne Inc. Common Stock
Helmerich & Payne, Inc. is a US drilling contractor that designs, builds, and operates high-performance land and offshore drilling rigs for oil and gas producers worldwide.
Read more on HP →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
